However, targeted AAV-mediated delivery of the CAG enhancer-promoter element to the Rian locus resulted in a rapid progression of HCC formation in all mice after AAV treatment, suggesting that a second mutation may not be necessary for HCC formation.53 Here, MEG8 is linked to hepatocellular carcinoma.